新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)-蛋白质/抗原/多肽-试剂-生物在线
新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)

新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)

商家询价

产品名称: 新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)

英文名称: Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)

产品编号: SPD-M180

产品价格: 0

产品产地: USA

品牌商标: ACROBiosystems

更新时间: null

使用范围: null

北京百普赛斯生物科技股份有限公司
  • 联系人 :
  • 地址 : 北京经济技术开发区宏达北路8号5号楼4层
  • 邮编 : 100176
  • 所在区域 : 北京
  • 电话 :
  • 传真 :
  • 邮箱 : order.cn@acrobiosystems.com

Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM128) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.98 μg/mL using SARS-CoV-2 Inhibitor Screening Kit (Cat. No. EP-105).Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.

Isotype

Human IgG1/kappa

Specificity

This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. Cross-reactivity with RBD of other coronaviruses has not been tested.

Purity

>95% as determined by SDS-PAGE.

Bioactivity